Gilead Sciences to Present at the 29th Annual JPMorgan Healthcare Conference on Monday, January 10
January 06 2011 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its
corporate presentation will be webcast from the 29th Annual
JPMorgan Healthcare Conference in San Francisco.
John C. Martin, PhD, Gilead’s Chairman and Chief Executive
Officer, will provide an overview of the company on Monday, January
10 at 3:30 p.m. Pacific Standard Time (6:30 p.m. Eastern Standard
Time).
To access the live webcast or a replay via the internet log on
to www.gilead.com. Please connect to the company’s website at least
15 minutes prior to the start of the presentation to ensure
adequate time for any software download that may be necessary to
listen to the webcast. The replay will be available for 14 days
following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead Sciences, please
visit www.gilead.com orcall the Gilead Public Affairs Department at
1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024